CRIS Current Research Information System

POTENA, LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.614
EU - Europa 2.985
AS - Asia 745
AF - Africa 187
OC - Oceania 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.608
GB - Regno Unito 707
IT - Italia 577
SE - Svezia 514
DE - Germania 414
CN - Cina 353
UA - Ucraina 224
IN - India 153
IE - Irlanda 152
VN - Vietnam 136
FR - Francia 100
RU - Federazione Russa 92
TG - Togo 65
BG - Bulgaria 55
JO - Giordania 55
ZA - Sudafrica 55
EE - Estonia 41
CH - Svizzera 33
CI - Costa d'Avorio 25
NG - Nigeria 25
FI - Finlandia 21
AT - Austria 17
JP - Giappone 17
SC - Seychelles 17
IR - Iran 16
BE - Belgio 13
CA - Canada 6
GR - Grecia 6
AU - Australia 5
EU - Europa 4
LB - Libano 4
NL - Olanda 4
PT - Portogallo 4
CL - Cile 3
CZ - Repubblica Ceca 3
HK - Hong Kong 3
RO - Romania 3
SG - Singapore 3
BR - Brasile 2
DK - Danimarca 2
KR - Corea 2
CO - Colombia 1
CY - Cipro 1
HU - Ungheria 1
MC - Monaco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TR - Turchia 1
Totale 7.547
Salva come PNG Salva come JPEG
Città #
Southend 621
Fairfield 414
Houston 381
Chandler 364
Ashburn 260
Woodbridge 217
Wilmington 208
Seattle 194
Princeton 182
Jacksonville 153
Dublin 152
Cambridge 151
Ann Arbor 121
Bologna 94
Bremen 81
New York 71
Westminster 66
Lomé 65
Padova 64
Nanjing 59
Berlin 57
Amman 55
Sofia 55
Dong Ket 49
Turin 47
Beijing 42
Shenyang 36
Mülheim 34
Redmond 32
Jinan 31
Medford 30
Saint Petersburg 30
Milan 29
Hebei 27
Abidjan 25
Florence 25
Abeokuta 24
San Diego 24
Bern 23
Changsha 22
Helsinki 21
Nanchang 19
Jiaxing 18
Mahé 17
Boardman 16
Rome 15
Tokyo 15
Verona 15
Vienna 15
Dearborn 14
Des Moines 13
Brussels 12
Olalla 12
Tianjin 12
Ningbo 10
Zhengzhou 10
Haikou 9
San Venanzo 9
Monmouth Junction 8
Kuban 7
Kunming 7
London 6
Los Angeles 6
Parma 6
Taiyuan 6
Taizhou 6
Boydton 5
Buffalo 5
Guangzhou 5
Norwalk 5
Pune 5
Redwood City 5
Ardabil 4
Bhubaneswar 4
Bühl 4
Ferrara 4
Hangzhou 4
Johannesburg 4
Las Vegas 4
Leawood 4
Lunano 4
Paris 4
Reggio Emilia 4
Toronto 4
Augusta 3
Bari 3
Basildon 3
Cento 3
Changchun 3
Costa Mesa 3
Falls Church 3
Frankfurt Am Main 3
Hefei 3
Hong Kong 3
Lanzhou 3
Lausanne 3
Moscow 3
Ravenna 3
Zanjan 3
Adrara San Martino 2
Totale 5.044
Salva come PNG Salva come JPEG
Nome #
Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. 319
L'inibitore endogeno della eNOS , la dimetil-arginina simmetrica (ADMA), è un nuovo fattore di rischio di vasculopatia coronarica post trapianto di cuore ed è infulenzato dalla terapia con sirolimus. 225
Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes 167
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 166
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 142
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 124
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 120
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 118
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 118
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 116
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. 115
Ischemic injury activates PTHrP and PTH1R expression in human ventricular cardiomyocytes. 115
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy 114
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 114
New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis. 114
Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation. 113
Diagnosi non invasiva di rigetto miocardico acuto: l'analisi armonica dell'ecg coadiuva la valutazione clinica 112
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. 112
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 111
Nitrates and Angina: an insight into arterial and venular involvement in blood flow regulation. 110
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 110
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 109
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue 105
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 105
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 105
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 101
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 99
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 99
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 99
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 98
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 97
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 94
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 94
Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions. 93
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 92
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 91
Potential of medical treatment, device therapy, and conventional surgery in patients referred for heart transplantation. 90
Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients 90
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 89
Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study. 87
Qualità della vita e parametri clinico-strumentali nello scompenso cardiaco. 87
Ruolo dell'NT-proBNP nella stratificazione prognostica dei pazienti con scompenso cardiaco cronico. 87
SAFETY AND EFFICACY OF TWO TYPES OF INFLUENZA VACCINATION IN HEART TRANSPLANT RECIPIENTS: A PROSPECTIVE RANDOMISED CONTROLLED STUDY 87
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 86
Heart transplantation in hypertrophic cardiomyopathy. 86
Psychological predictors of mortality in heart transplanted patients: a prospective, 6-year follow-up study. 85
null 85
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 84
Prevalence of substance-related disorders in heart transplantation candidates 84
Manifestations of health anxiety in patients with heart transplant 84
La progressione della coronarografia del graft è proporzionale alla severità dell'infezione da citomegalovirus nei pazienti con trapianto cardiaco. 81
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 81
Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome 80
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 79
L'inibitore endogeno della eNOS favorisce la progressione dell'infezione da cytoomegalovirus e del rigetto miocardico acuto nei pazienti con trapianto di cuore. 78
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 78
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 77
Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. 76
Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. 75
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. 75
Extracorporeal Membrane Oxygenation Support System as Bridge to Solution in Refractory Cardiogenic Shock 74
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 72
Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality = Sistemi di ossigenazione a membrana extracorporea come trattamento per lo shock cardiogeno refrattario nella popolazione adulta: strategie, risultati e predittori di mortalità 71
Impact of Current Donor Scores Calculation on Heart Transplantation Outcomes 71
L'infezione subclinica da citomegalovirus modula l'infiammazione sistemica e il rimodellamento coronarico ad un anno dal trapianto. 70
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 67
Role of Donor-Recipient Match in Determining the Risk for Primary Graft Failure after Heart Transplantation 65
Study Design and Preliminary Results of the Italian Everolimus Registry CERTIC 64
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 61
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 57
Studio prospettico randomizzato sull'effetto della terapia con acido folico nella preenzione della malattia coronarica nel paziente trapiantato 57
Viral genome search in myocardium of patients with fulminant myocarditis 56
COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak 53
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 52
Management of heart transplant candidates in the time of COVID-19 pandemic: Looking for answers 51
Impact of prior sternotomy on survival and allograft function after heart transplantation: A single center matched analysis 48
Multiple organ retrieval in a brain dead left ventricular assist device donor 45
Donor risk analysis and validation in heart transplants: A single-centre experience 42
Donor-derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: A case report 42
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 38
Heart rate reserve during dipyridamole stress test applied to potential heart donors in brain death 32
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 28
Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy 27
Evidence and current use of levosimendan in the treatment of heart failure: Filling the gap 27
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 25
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 21
Impact of Predicted Heart Mass–Based Donor-Recipient Size Matching on Transplant Outcomes 20
Clinical profile and in-hospital outcome of patients supported by intra-aortic balloon pump in the clinical setting of cardiogenic shock 19
Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias 17
Candidacy for heart transplantation in adult congenital heart disease patients: A cohort study 16
Pretransplant Right Ventricular Dysfunction Is Associated With Increased Mortality After Heart Transplantation: A Hard Inheritance to Overcome 16
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients? 15
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease 14
Longest reported support (7.5 years) with postauricular type of Jarvik 2000 axial-flow left ventricular assist device 12
Overcoming challenges in patient selection and monitoring in combined heart and kidney transplantation 11
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians 8
Role of Quantitative Flow Ratio in Predicting Future Cardiac Allograft Vasculopathy in Heart Transplant Recipients 6
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 5
Prolactin Inhibition to Treat Postpartum Arrhythmic Storm 3
New insights into the oncological risk in heart transplant recipients: could skin tumors represent a marker of increased risk for solid neoplasm? 1
Totale 7.806
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019230 0 0 0 0 0 0 0 0 0 79 30 121
2019/20202.038 323 52 61 160 225 216 214 229 231 133 76 118
2020/2021927 220 59 24 56 26 38 53 45 78 66 42 220
2021/20221.475 60 49 96 210 119 62 39 113 59 139 297 232
2022/20231.940 171 236 100 231 172 174 50 106 359 77 183 81
2023/2024618 36 98 36 72 29 164 41 54 33 55 0 0
Totale 7.809